Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Increasing Levels of Serum Heat Shock Protein 70 Precede the Development of AIDS-Defining Non-Hodgkin Lymphoma Among Carriers of HLA-B8-DR3.

Aissani B, Martinez-Maza O, Kaslow RA, Wiener HW, Bream JH, Stosor V, Martinson JJ, Jacobson LP, Shrestha S.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):266-273. doi: 10.1097/QAI.0000000000002027.

2.

Access, Education and Policy Awareness: Predictors of Influenza Vaccine Acceptance Among VHA Healthcare Workers.

Eaton JL, Mohr DC, McPhaul KM, Kaslow RA, Martinello RA.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):970-975. doi: 10.1017/ice.2017.113. Epub 2017 Jun 23.

PMID:
28641586
3.

CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data.

Tang J, Li X, Price MA, Sanders EJ, Anzala O, Karita E, Kamali A, Lakhi S, Allen S, Hunter E, Kaslow RA, Gilmour J.

Front Microbiol. 2015 Jul 1;6:670. doi: 10.3389/fmicb.2015.00670. eCollection 2015.

4.

Immunogenetic influences on acquisition of HIV-1 infection: consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2).

Li X, Zhang K, Pajewski NM, Brill I, Prentice HA, Shrestha S, Kilembe W, Karita E, Allen S, Hunter E, Kaslow RA, Tang J.

Genes Immun. 2015 Apr-May;16(3):213-20. doi: 10.1038/gene.2014.84. Epub 2015 Jan 29.

5.

Body Mass Index Is Associated With Mucosal Disease in Crohn's: Results of a Case-Control Study.

Malik TA, Kaslow RA, Cofield SS, Mannon PJ.

Gastroenterology Res. 2014 Dec;7(5-6):111-117. Epub 2014 Dec 27.

6.

SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcoma.

Aissani B, Boehme AK, Wiener HW, Shrestha S, Jacobson LP, Kaslow RA.

Genes Immun. 2014 Sep;15(6):424-9. doi: 10.1038/gene.2014.42. Epub 2014 Jul 10.

7.

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions.

Li X, Price MA, He D, Kamali A, Karita E, Lakhi S, Sanders EJ, Anzala O, Amornkul PN, Allen S, Hunter E, Kaslow RA, Gilmour J, Tang J; IAVI Africa HIV Prevention Partnership.

Hum Genet. 2014 Sep;133(9):1187-97. doi: 10.1007/s00439-014-1465-x. Epub 2014 Jun 27.

8.

Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans.

Aissani B, Shrestha S, Wiener HW, Tang J, Kaslow RA, Wilson CM.

AIDS. 2014 Aug 24;28(13):1871-8. doi: 10.1097/QAD.0000000000000371.

9.

KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function.

Merino AM, Dugast AS, Wilson CM, Goepfert PA, Alter G, Kaslow RA, Tang J.

PLoS One. 2014 Jun 5;9(6):e99353. doi: 10.1371/journal.pone.0099353. eCollection 2014.

10.

Host genetics and immune control of HIV-1 infection: fine mapping for the extended human MHC region in an African cohort.

Prentice HA, Pajewski NM, He D, Zhang K, Brown EE, Kilembe W, Allen S, Hunter E, Kaslow RA, Tang J.

Genes Immun. 2014 Jul-Aug;15(5):275-81. doi: 10.1038/gene.2014.16. Epub 2014 May 1.

11.

Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.

Prentice HA, Price MA, Porter TR, Cormier E, Mugavero MJ, Kamali A, Karita E, Lakhi S, Sanders EJ, Anzala O, Amornkul PN, Allen S, Hunter E, Kaslow RA, Gilmour J, Tang J; IAVI Africa HIV Prevention Partnership.

Virology. 2014 Jan 20;449:254-62. doi: 10.1016/j.virol.2013.11.024. Epub 2013 Dec 12.

12.

Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Li X, Wu J, Ptacek T, Redden DT, Brown EE, Alarcón GS, Ramsey-Goldman R, Petri MA, Reveille JD, Kaslow RA, Kimberly RP, Edberg JC.

Sci Transl Med. 2013 Dec 18;5(216):216ra175. doi: 10.1126/scitranslmed.3007097.

13.

Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.

Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J.

Clin Exp Immunol. 2013 Dec;174(3):414-23. doi: 10.1111/cei.12187.

14.

A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma.

Aissani B, Wiener HW, Zhang K, Kaslow RA, Ogwaro KM, Shrestha S, Jacobson LP.

Int J Cancer. 2014 Jan 15;134(2):397-404. doi: 10.1002/ijc.28351. Epub 2013 Jul 27.

15.

Genomic copy number variants: evidence for association with antibody response to anthrax vaccine adsorbed.

Falola MI, Wiener HW, Wineinger NE, Cutter GR, Kimberly RP, Edberg JC, Arnett DK, Kaslow RA, Tang J, Shrestha S.

PLoS One. 2013 May 31;8(5):e64813. doi: 10.1371/journal.pone.0064813. Print 2013.

16.

Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.

Ovsyannikova IG, Pankratz VS, Vierkant RA, Pajewski NM, Quinn CP, Kaslow RA, Jacobson RM, Poland GA.

Infect Immun. 2013 Jul;81(7):2584-91. doi: 10.1128/IAI.00269-13. Epub 2013 May 6.

17.

Disparities in lung transplantation before and after introduction of the lung allocation score.

Wille KM, Harrington KF, deAndrade JA, Vishin S, Oster RA, Kaslow RA.

J Heart Lung Transplant. 2013 Jul;32(7):684-92. doi: 10.1016/j.healun.2013.03.005. Epub 2013 Apr 9.

18.

Structure of tumor necrosis factor-alpha haploblocks in European populations.

Merino AM, Zhang K, Kaslow RA, Aissani B.

Immunogenetics. 2013 Jul;65(7):543-52. doi: 10.1007/s00251-013-0700-2. Epub 2013 Apr 12.

19.

HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?

Prentice HA, Porter TR, Price MA, Cormier E, He D, Farmer PK, Kamali A, Karita E, Lakhi S, Sanders EJ, Anzala O, Amornkul PN, Allen S, Hunter E, Kaslow RA, Gilmour J, Tang J; IAVI African HIV Research Network.

J Virol. 2013 Apr;87(7):4043-51. doi: 10.1128/JVI.03302-12. Epub 2013 Jan 30.

20.

Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.

Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Prentice HA, Yue L, Vishwanathan SA, Kilembe W, Goepfert P, Price MA, Gilmour J, Mulenga J, Farmer P, Derdeyn CA, Tang J, Heckerman D, Kaslow RA, Allen SA, Hunter E.

PLoS Pathog. 2012;8(11):e1003041. doi: 10.1371/journal.ppat.1003041. Epub 2012 Nov 29.

21.

Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.

Yue L, Prentice HA, Farmer P, Song W, He D, Lakhi S, Goepfert P, Gilmour J, Allen S, Tang J, Kaslow RA, Hunter E.

J Virol. 2013 Jan;87(2):708-15. doi: 10.1128/JVI.02118-12. Epub 2012 Oct 31.

22.

A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed.

Pajewski NM, Shrestha S, Quinn CP, Parker SD, Wiener H, Aissani B, McKinney BA, Poland GA, Edberg JC, Kimberly RP, Tang J, Kaslow RA.

Vaccine. 2012 Jul 6;30(32):4778-84. doi: 10.1016/j.vaccine.2012.05.032. Epub 2012 May 31.

23.

Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.

Shrestha S, Wiener H, Shendre A, Kaslow RA, Wu J, Olson A, Bowles NE, Patel H, Edberg JC, Portman MA.

Circ Cardiovasc Genet. 2012 Jun;5(3):309-16. doi: 10.1161/CIRCGENETICS.111.962464. Epub 2012 May 7.

24.

HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load.

Merino AM, Song W, He D, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA.

J Infect Dis. 2012 Jun 15;205(12):1797-805. doi: 10.1093/infdis/jis275. Epub 2012 Apr 5.

25.

Genetic variations and heterosexual HIV-1 infection: analysis of clustered genes encoding CC-motif chemokine ligands.

Hu L, Song W, Brill I, Mulenga J, Allen S, Hunter E, Shrestha S, Tang J, Kaslow RA.

Genes Immun. 2012 Feb;13(2):202-5. doi: 10.1038/gene.2011.70. Epub 2011 Oct 6. Erratum in: Genes Immun. 2012 Jul;13(5):444.

26.

Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.

Song W, He D, Brill I, Malhotra R, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA.

PLoS One. 2011;6(8):e23469. doi: 10.1371/journal.pone.0023469. Epub 2011 Aug 17.

27.

Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.

Tang J, Cormier E, Gilmour J, Price MA, Prentice HA, Song W, Kamali A, Karita E, Lakhi S, Sanders EJ, Anzala O, Amornkul PN, Allen S, Hunter E, Kaslow RA; IAVI African HIV Research Network.

J Virol. 2011 Sep;85(17):8894-902. doi: 10.1128/JVI.00439-11. Epub 2011 Jun 29.

28.

B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1303-14. doi: 10.1158/1055-9965.EPI-11-0037. Epub 2011 Apr 28.

29.

Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.

Malhotra R, Hu L, Song W, Brill I, Mulenga J, Allen S, Hunter E, Shrestha S, Tang J, Kaslow RA.

Retrovirology. 2011 Mar 23;8:22. doi: 10.1186/1742-4690-8-22.

30.

The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed.

Pajewski NM, Parker SD, Poland GA, Ovsyannikova IG, Song W, Zhang K, McKinney BA, Pankratz VS, Edberg JC, Kimberly RP, Jacobson RM, Tang J, Kaslow RA.

Genes Immun. 2011 Sep;12(6):457-65. doi: 10.1038/gene.2011.15. Epub 2011 Mar 3.

31.

The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.

Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, McNicholl JM, Gardner LI, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J, Kaslow RA; HIV Epidemiology Research Study Group; Reaching for Excellence in Adolescent Care and Health Study Group.

Hum Immunol. 2011 Apr;72(4):312-8. doi: 10.1016/j.humimm.2011.01.003. Epub 2011 Jan 21.

32.

Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples.

Merino A, Malhotra R, Morton M, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA.

J Infect Dis. 2011 Feb 15;203(4):487-95. doi: 10.1093/infdis/jiq075. Epub 2011 Jan 7.

33.

Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.

Beachler DC, Gellert LL, Jacobson LP, Ambinder RF, Breen EC, Martínez-Maza O, Rabkin CS, Kaslow RA, D'Souza G.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):188-92. doi: 10.1097/QAI.0b013e3181ff976b. Erratum in: J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e103. Rabkin, Charles C [corrected to Rabkin, Charles S].

34.

Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents.

Shrestha S, Wiener HW, Aissani B, Song W, Shendre A, Wilson CM, Kaslow RA, Tang J.

PLoS One. 2010 Oct 14;5(10):e13384. doi: 10.1371/journal.pone.0013384.

35.

Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.

Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, Kaslow RA, Jacobson LP, Ambinder RF, Chanock S, Martínez-Maza O, Rabkin CS.

AIDS. 2010 Apr 24;24(7):1025-33. doi: 10.1097/QAD.0b013e328332d5b1. Erratum in: AIDS. 2010 Jul 31;24(12):1973.

36.

Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships.

Tang J, Malhotra R, Song W, Brill I, Hu L, Farmer PK, Mulenga J, Allen S, Hunter E, Kaslow RA.

PLoS One. 2010 Mar 10;5(3):e9629. doi: 10.1371/journal.pone.0009629.

37.

CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription.

Bansal A, Carlson J, Yan J, Akinsiku OT, Schaefer M, Sabbaj S, Bet A, Levy DN, Heath S, Tang J, Kaslow RA, Walker BD, Ndung'u T, Goulder PJ, Heckerman D, Hunter E, Goepfert PA.

J Exp Med. 2010 Jan 18;207(1):51-9. doi: 10.1084/jem.20092060. Epub 2010 Jan 11.

38.

Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.

Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI.

J Infect Dis. 2010 Feb 15;201(4):618-26. doi: 10.1086/649842.

39.

Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.

Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, Gardner LI, McNicholl JM, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J, Kaslow RA; HIV Epidemiology Research Study; Reaching for Excellence in Adolescent Care and Health Study.

J Virol. 2010 Mar;84(5):2610-7. doi: 10.1128/JVI.01962-09. Epub 2009 Dec 23.

40.

Gene copy number: learning to count past two.

Shrestha S, Tang J, Kaslow RA.

Nat Med. 2009 Oct;15(10):1127-9. doi: 10.1038/nm1009-1127. No abstract available.

PMID:
19812568
41.

Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

Song W, Ruder AM, Hu L, Li Y, Ni R, Shao W, Kaslow RA, Butler M, Tang J.

PLoS One. 2009 Sep 23;4(9):e7157. doi: 10.1371/journal.pone.0007157.

42.

The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.

Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, Jacobson LP, Rabkin CS, Ambinder RF, Martinez-Maza O, Kaslow RA.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):170-9. doi: 10.1097/QAI.0b013e3181b017d5.

43.

Host genetics and HIV-1 viral load set-point in African-Americans.

Shrestha S, Aissani B, Song W, Wilson CM, Kaslow RA, Tang J.

AIDS. 2009 Mar 27;23(6):673-7. doi: 10.1097/QAD.0b013e328325d414.

44.

Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.

Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Chatham A, Raper JL, Kaslow RA, Saag MS, Mugavero MJ.

AIDS. 2008 Oct 1;22(15):1951-60. doi: 10.1097/QAD.0b013e32830efd79.

45.

Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.

Tang J, Shao W, Yoo YJ, Brill I, Mulenga J, Allen S, Hunter E, Kaslow RA.

J Immunol. 2008 Aug 15;181(4):2626-35.

46.

Immunogenetic correlates of Neisseria gonorrhoeae infection in adolescents.

Geisler WM, Wang C, Tang J, Wilson CM, Crowley-Nowick PA, Kaslow RA.

Sex Transm Dis. 2008 Jul;35(7):656-61. doi: 10.1097/OLQ.0b013e31816b6593.

47.

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, Derdeyn CA, Tang J, Kaslow RA, Bansal A, Yusim K, Heckerman D, Mulenga J, Allen S, Goulder PJ, Hunter E.

J Exp Med. 2008 May 12;205(5):1009-17. doi: 10.1084/jem.20072457. Epub 2008 Apr 21.

48.

Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.

Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):553-8. doi: 10.1097/QAI.0b013e31816856c5.

PMID:
18285713
49.

Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected].

Apte M, McGwin G Jr, Vilá LM, Kaslow RA, Alarcón GS, Reveille JD; LUMINA Study Group.

Rheumatology (Oxford). 2008 Mar;47(3):362-7. doi: 10.1093/rheumatology/kem371. Epub 2008 Feb 4. Erratum in: Rheumatology (Oxford).2008 May;47(5): 742.

PMID:
18250089
50.

Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.

Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA.

AIDS. 2007 Nov 30;21(18):2387-97.

Supplemental Content

Loading ...
Support Center